SciTransfer
Organization

PENTABIOL SL

Spanish agri-tech SME developing functional animal feed to improve livestock health and production, EU SME Instrument Phase 1 and Phase 2 grantee.

Technology SMEfoodESSMENo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
2
Total EC funding
€1.3M
Unique partners
0
What they do

Their core work

PENTABIOL SL is a Spanish agri-tech SME specialising in animal nutrition, developing functional fodder and feed products designed to improve animal health and livestock production performance. Their core work centers on formulating feed solutions that reduce the need for veterinary interventions — likely through probiotic, prebiotic, or bioactive feed additives that support gut health and immunity in farm animals. Operating out of Navarra, a major Spanish agricultural region, they serve the livestock production chain from feed formulation through to measurable productivity outcomes. Their successful progression from EU feasibility funding to full-scale implementation grant confirms their technology passed independent expert review at both commercial and technical levels.

Core expertise

What they specialise in

Functional animal feed and fodder formulationprimary
2 projects

Both HEALTHSTOCK projects (2015 feasibility and 2016–2018 implementation) are explicitly focused on fodder for healthier animals and improved livestock production.

Livestock health optimisation through nutritionprimary
2 projects

The HEALTHSTOCK title and description indicate the product's mechanism is improving animal health outcomes — not just yield — through feed composition.

2 projects

The sequential use of SME Instrument Phase 1 (feasibility, €50k) and Phase 2 (market launch, €1.28M) shows deliberate commercialisation of a proprietary feed technology.

Evolution & trajectory

How they've shifted over time

Early focus
Animal feed feasibility study
Recent focus
Livestock feed market launch

PENTABIOL's H2020 activity is contained within a tight two-year window (2015–2016 start dates), both under the same HEALTHSTOCK brand, making it impossible to detect a meaningful shift in focus across time. The Phase 1 to Phase 2 progression represents deepening commitment to the same technology rather than a change in direction. No keyword data is available for either period, so any claim about thematic evolution would be speculative.

PENTABIOL appears to have used H2020 as a launchpad for a single proprietary product; whether they continued R&D activity after 2018 is unknown from available data.

Collaboration profile

How they like to work

Role: consortium_leaderReach: Local

PENTABIOL led both of their H2020 projects as sole coordinator with no recorded consortium partners — a pattern typical of SME Instrument grantees, where individual companies develop and commercialise their own innovations without requiring research partners. This means they are experienced at managing EU project obligations independently, but have no demonstrated track record of multi-partner collaboration. A consortium builder should expect them to contribute as a focused specialist rather than a co-lead seeking shared governance.

PENTABIOL has no recorded consortium partners across their two H2020 projects, which reflects the solo-company structure of the SME Instrument rather than geographic or strategic isolation. Their effective collaboration network within the EU research system is, based on available data, limited to zero external partners.

Why partner with them

What sets them apart

PENTABIOL's distinguishing feature is that they developed a proprietary animal feed product compelling enough to win both phases of the highly competitive EU SME Instrument — a two-stage process that rejects the majority of applicants. This positions them as a validated product company rather than a generic feed supplier, with an independently reviewed business case. For consortium builders in the food-agriculture space, they offer direct industry access to the livestock feed market in Spain and potentially wider Iberian markets.

Notable projects

Highlights from their portfolio

  • HEALTHSTOCK
    Successfully secured both Phase 1 (€50k feasibility) and Phase 2 (€1.28M implementation) of the EU SME Instrument for the same livestock feed technology — a rare double-phase progression that signals strong commercial validation.
Cross-sector capabilities
Animal health and veterinary nutritionSustainable livestock productionBioactive ingredient supply chains
Analysis note: Only 2 projects, both under the same HEALTHSTOCK brand, with no keyword data and no consortium partners recorded. The profile is coherent but thin — expertise claims are inferred from project titles and funding scheme logic, not from detailed technical descriptions. Do not cite specific technologies (e.g. probiotics) as confirmed facts without verifying against the actual project deliverables.